MBTPS1 and myeloid sarcoma: Furthermore, S1P expression in astrocytes has been shown to influence the severity of experimental autoimmune encephalomyelitis, and relevant data suggested that the S1P signaling pathway in the CNS was a target for MS therapy (35).